Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The fund will help to develop initiatives to support researchers of color and increase diversity in cancer research and patient care.
A collective of Southern Black activists issues a political agenda to renew the fight against HIV.
4% of total U.S. AIDS philanthropy directly addresses African Americans. Plus: Meet the top five funders helping BIPOC communities.
Gilead Sciences provides the funds through its TRANScend initiative; Destination Tomorrow in the Bronx distributes them.
UPDATE: The county health department restored funding through the end of March. Here’s how you can ensure it lasts longer.
The American Cancer Society sets the record straight.
Older people who learn they have HIV are likely to have been positive for 4.5 years—the longest diagnosis delay of any age group.
The executive director of Funders Concerned About AIDS asks: How can we ensure that the HIV epidemic has sufficient media “air time”?
Venita Ray will manage the group’s role in the $100 million COMPASS initiative.
For example: Hep C cures have meant fewer people to treat and fewer transmissions to potential patients.
Experts are calling for an additional $100 million to fund the CDC’s Viral Hepatitis programs.
The Gilead Sciences funding will be carried out in partnership with the Black AIDS Institute.
An estimated 51.2 million people in the U.S. had at least one mental disorder in the past year.
Participants in Kenya’s grant program for poor orphans and other vulnerable children start having sex later, and they have sex less often, tha...
Overall, low- and middle-income countries are now investing more in domestic HIV spending than they receive from international HIV funding.
On July 18, Republicans on the House Labor, HHS, Education and Related Agencies Appropriations Subcommittee approved a bill that would...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.